Published in J Natl Cancer Inst on December 01, 1972
The status of CMV as a human pathogen. Epidemiol Infect (1988) 1.17
In vitro study of the cell populations in two cases of Kaposi's sarcoma. Arch Dermatol Res (1986) 0.75
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol (1999) 11.78
Aspergillosis. The spectrum of the disease in 98 patients. Medicine (Baltimore) (1970) 5.98
Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet (1970) 2.11
Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol (2001) 2.11
Kaposi's sarcoma in Uganda: a clinico-pathological study. Int J Cancer (1971) 2.06
Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer (1980) 1.90
Liver cell dysplasia: a premalignant condition. J Clin Pathol (1973) 1.66
Urinary neopterin and immunological features in patients with Kaposi's sarcoma. Eur J Cancer Clin Oncol (1988) 1.50
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol (1996) 1.44
Immunological effects of BCG in malignant melanoma: two modes of administration compared. Ann Intern Med (1972) 1.43
[Coagulation evaluation and locoregional anesthesia]. Ann Fr Anesth Reanim (1991) 1.38
Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies. Int J Cancer (1981) 1.26
Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer (1980) 1.26
Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of American Kaposi's sarcoma with cytomegalovirus. Int J Cancer (1978) 1.25
Herpes-type virus particles in tissue culture of Kaposi's sarcoma from different geographic regions. J Natl Cancer Inst (1972) 1.24
Human papillomavirus (HPV) DNA in penile carcinomas and in two cell lines from high-incidence areas for genital cancers in Africa. Int J Cancer (1992) 1.18
Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer (1996) 1.18
Kaposi's sarcoma: a comparison of classical, endemic, and epidemic forms. Semin Oncol (1984) 1.16
Treatment of Kaposi's sarcoma with actinomycin-D and cyclophosphamide: results of a randomized clinical trial. Int J Cancer (1971) 1.16
Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial. Oncology (2002) 1.15
Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A. Antiviral Res (2002) 1.12
Hepatitis-associated antigen and antibody in hepatocellular carcinoma: results of a continuing study. J Natl Cancer Inst (1972) 1.11
Pneumocystis carinii pneumonia. Ann Intern Med (1968) 1.10
Hepatitis B virus infection and primary hepatocellular carcinoma. J Natl Cancer Inst (1977) 1.10
The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor beta gene expression through a TAR-like structure. J Virol (1994) 1.09
A review of vinorelbine in the treatment of breast cancer. Clin Breast Cancer (2001) 1.09
A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States. Cancer (1977) 1.08
Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer (1976) 1.06
C8 deficiency in a family with xeroderma pigmentosum. Lack of linkage to the HLA region. Clin Immunol Immunopathol (1977) 1.06
Familial chronic lymphocytic leukemia. Ann Intern Med (1969) 1.06
High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. Antiviral Res (2001) 1.05
Hepatitis-associated antigen and antibody in Uganda: correlation of serological testing with histopathology. Br Med J (1972) 1.04
Etiological implications on Kaposi's sarcoma. Antibiot Chemother (1971) (1981) 1.01
Antibody patterns to herpesviruses in kaposi's sarcoma: serological association of european kaposi's sarcoma with cytomegalovirus. Int J Cancer (1975) 1.00
Detection of early antigens in nuclei of cells infected with cytomegalovirus or herpes simplex virus type 1 and 2 by anti-complement immunofluorescence, and use of a blocking assay to demonstrate their specificity. Int J Cancer (1977) 1.00
Studies on levamisole--induced agranulocytosis. Blood (1980) 0.98
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. J Pain Symptom Manage (1991) 0.97
Serum alpha-fetoprotein in 184 Ugandan patients with hepatocellular carcinoma. Clinical, laboratory, and histopathologic correlations. Cancer (1974) 0.97
Aspergillus lobar pneumonia. JAMA (1969) 0.97
A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Cancer (1975) 0.96
Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer. J Clin Oncol (1995) 0.96
Herpesvirus-like DNA sequences in non-AIDS Kaposi's sarcoma. J Infect Dis (1995) 0.95
Treatment of Kaposi's sarcoma with a combination of actinomycin D and vincristine. Results of a randomized clinical trial. Cancer (1973) 0.94
Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology (1993) 0.94
Sarcomas and multiple polyposis in a kindred. A genetic variety of hereditary polyposis? Arch Intern Med (1968) 0.92
Burkitt's tumor in the United States. Cancer (1969) 0.92
Identification and functional analysis of sequence rearrangements in the long control region of human papillomavirus type 16 Af-1 variants isolated from Ugandan penile carcinomas. J Gen Virol (2000) 0.92
A novel glycoprotein 120 sequence from an HIV type 1 isolate of the A clade identified in North Uganda. AIDS Res Hum Retroviruses (1998) 0.91
The role of immunosuppression and immune-activation in classic Kaposi's sarcoma. Int J Cancer (1999) 0.91
Secretion of methotrexate into human milk. Am J Obstet Gynecol (1972) 0.90
Immunological studies in Ugandan patients with hepatocellular carcinoma. Br Med J (1973) 0.89
The uganda study on HPV variants and genital cancers. J Clin Virol (2000) 0.89
Solid-phase immune electron microscopy-double-antibody technique for rapid detection of papovaviruses. J Clin Microbiol (1982) 0.89
Serum alpha-fetoprotein as a biochemical marker for hepatocellular carcinoma. Cancer Res (1972) 0.88
Leukemia virus release in chemically or physically induced lymphomas in BALB-c mice. Natl Cancer Inst Monogr (1966) 0.87
Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg (1998) 0.87
Value of 8S/4S fractionation of estrogen receptors (ER) for prediction of response to hormonal manipulation in metastatic breast cancer. Breast Cancer Res Treat (1984) 0.86
Sequence variations and viral genomic state of human papillomavirus type 16 in penile carcinomas from Ugandan patients. J Gen Virol (1997) 0.86
Enhanced suppression of experimental allergic encephalomyelitis by combination chemotherapy with duazomycin-A and 6-mercaptopurine. Proc Soc Exp Biol Med (1969) 0.86
Dopa and 5-S-cysteinyldopa in malignant melanoma in Ugandan Africans. Acta Derm Venereol (1974) 0.85
Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome. Leukemia (1999) 0.85
Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) Trial. Eur J Cancer (1992) 0.85
Interspecies-, species- and type-specific T antigenic determinants of human papovaviruses (JC and BK) and of Simian virus 40. Int J Cancer (1977) 0.83
Protocollagen proline hydroxylase in sera of Ugandans with hepatocellular carcinoma. J Natl Cancer Inst (1972) 0.83
Immunosuppressive action of L-asparaginase. Lancet (1969) 0.82
Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative. Cancer Res (1969) 0.82
Glutamate dehydrogenase activity related to histopathological grade of hepatocellular carcinoma in man. Cancer Res (1974) 0.82
Ultrastructural survey of primary liver cell carcinomas from Uganda. J Natl Cancer Inst (1972) 0.82
Human sarcomas in culture. Foci of altered cells and a common antigen; induction of foci and antigen in human fibroblast cultures by filtrates. J Exp Med (1971) 0.81
Distinct chromosome 3 abnormalities in persistent polyclonal B-cell lymphocytosis. Genes Chromosomes Cancer (1999) 0.81
Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388). Cancer Chemother Rep (1973) 0.81
Phase II study of oral etoposide for patients with advanced breast cancer. Cancer (1995) 0.81
Reliability of clinical estrogen receptor assays performed on tumor tissue biopsied from sites previously treated with radiotherapy. Surgery (1979) 0.81
BK virus-transformed inbred hamster brain cells: status of viral DNA in subclones. Mol Cell Biol (1982) 0.80
BK virus DNA in Kaposi's sarcoma. Antibiot Chemother (1971) (1987) 0.80
Ectopic production of human chorionic gonadotropin in Ugandan patients with hepatocellular carcinoma. Cancer (1973) 0.80
Microfluorometric analysis of anti-complement and indirect immunofluorescence tests for human papovavirus (JCV and BKV) T antigens. Int J Cancer (1978) 0.80
Reciprocal interference between mouse mammary tumour virus and leukaemia virus. Nature (1967) 0.80
Role of HIV as cofactor in HPV oncogenesis: in vitro evidences of virus interactions. Antibiot Chemother (1971) (1994) 0.79
Mitogen-induced blastogenesis and receptor mobility inhibition by breast cancer serum with elevated orosomucoid (alpha 1-acid glycoprotein) levels. J Natl Cancer Inst (1982) 0.79
BK virus-transformed inbred hamster brain cells. I. Status of the viral DNA and the association of BK virus early antigens with purified plasma membranes. J Virol (1981) 0.79
Cytogenetic study of a cell line of human penile cancer. Ann Genet (1987) 0.79